Literature DB >> 17084798

A 5-year evaluation of a methadone medical maintenance program.

Kenneth A Harris1, Julia H Arnsten, Herman Joseph, Joe Hecht, Ira Marion, Patti Juliana, Marc N Gourevitch.   

Abstract

Methadone medical maintenance (MMM) is a model for the treatment of opioid dependence in which a monthly supply of methadone is distributed in an office setting, in contrast to more highly regulated settings where daily observed dosing is the norm. We assessed patient characteristics and treatment outcomes of an MMM program initiated in the Bronx, New York, in 1999 by conducting a retrospective chart review. Participant characteristics were compared with those of patients enrolled in affiliated conventional methadone maintenance treatment programs. Patients had diverse ethnicities, occupations, educational backgrounds, and income levels. Urine toxicology testing detected illicit opiate and cocaine use in 0.8% and 0.4% of aggregate samples, respectively. The retention rate was 98%, which compares favorably with the four other MMM programs that have been reported in the medical literature. This study demonstrates that selected patients from a socioeconomically disadvantaged population remained clinically stable and engaged in treatment in a far less intensive setting than traditional methadone maintenance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084798      PMCID: PMC2692058          DOI: 10.1016/j.jsat.2006.05.018

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  33 in total

1.  Involvement of community pharmacists in the care of drug misusers: pharmacy-based supervision of methadone consumption.

Authors: 
Journal:  Int J Drug Policy       Date:  2000-05-01

2.  Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.

Authors:  Eric C Donny; Susan M Brasser; George E Bigelow; Maxine L Stitzer; Sharon L Walsh
Journal:  Addiction       Date:  2005-10       Impact factor: 6.526

3.  Long-term outcome of patients treated with methadone maintenance.

Authors:  V P Dole; H Joseph
Journal:  Ann N Y Acad Sci       Date:  1978       Impact factor: 5.691

4.  Medical maintenance: an interim report.

Authors:  E C Senay; A Barthwell; R Marks; P J Bokos
Journal:  J Addict Dis       Date:  1994

5.  Medical maintenance: a pilot study.

Authors:  E C Senay; A G Barthwell; R Marks; P Bokos; D Gillman; R White
Journal:  J Addict Dis       Date:  1993

Review 6.  Methadone maintenance treatment (MMT): a review of historical and clinical issues.

Authors:  H Joseph; S Stancliff; J Langrod
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

7.  Methadone medical maintenance in primary care. An implementation evaluation.

Authors:  Joseph O Merrill; T Ron Jackson; Beryl A Schulman; Andrew J Saxon; Asaad Awan; Sonja Kapitan; Molly Carney; Lyndia C Brumback; Dennis Donovan
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

8.  Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance): follow-up at three and a half to nine and a fourth years.

Authors:  D M Novick; H Joseph; E A Salsitz; M F Kalin; J B Keefe; E L Miller; B L Richman
Journal:  J Gen Intern Med       Date:  1994-03       Impact factor: 5.128

9.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

10.  "Living with the dirty secret": problems of disclosure for methadone maintenance clients.

Authors:  S Murphy; J Irwin
Journal:  J Psychoactive Drugs       Date:  1992 Jul-Sep
View more
  7 in total

1.  Increases in the availability of prescribed opioids in a Canadian setting.

Authors:  B Nosyk; B D L Marshall; B Fischer; J S G Montaner; E Wood; T Kerr
Journal:  Drug Alcohol Depend       Date:  2012-04-04       Impact factor: 4.492

2.  Methadone treatments in a Swiss region, 2001-2008: a registry-based analysis.

Authors:  Thérèse Huissoud; Valentin Rousson; Françoise Dubois-Arber
Journal:  BMC Psychiatry       Date:  2012-12-28       Impact factor: 3.630

3.  Simultaneous determination of methadone and morphine at a modified electrode with 3D β-MnO2 nanoflowers: application for pharmaceutical sample analysis.

Authors:  Sedigheh Akbari; Shohreh Jahani; Mohammad Mehdi Foroughi; Hadi Hassani Nadiki
Journal:  RSC Adv       Date:  2020-10-19       Impact factor: 4.036

4.  Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.

Authors:  Li-Tzy Wu; William S John; Eric D Morse; Steve Adkins; Jennifer Pippin; Robert K Brooner; Robert P Schwartz
Journal:  Addiction       Date:  2021-08-16       Impact factor: 6.526

Review 5.  Pharmacologic treatments for opioid dependence: detoxification and maintenance options.

Authors:  Herbert D Kleber
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

6.  Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review.

Authors:  Dennis McCarty; Christina Bougatsos; Brian Chan; Kim A Hoffman; Kelsey C Priest; Sara Grusing; Roger Chou
Journal:  Am J Psychiatry       Date:  2021-07-28       Impact factor: 19.242

7.  Experiences of opium dependents from performance of methadone centers of kerman, iran.

Authors:  Nabi Banazadeh Mahani; Ali Kheradmand; Heidarali Abedi
Journal:  Addict Health       Date:  2009
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.